Martin Hoenigl
martinhoenigl.bsky.social
Martin Hoenigl
@martinhoenigl.bsky.social
Tenure Track Prof for Translational Mycology, Medical University Graz, Austria; Past President ECMM.❤️for Clinical Mycology, ⬛⬜1909 ⚽️ Rams 🏈#StandwithUkraine
Pinned
👉Participate in ECMM Candida IV

🌎wide study on candidemia caused by non-albicans Candida spp.

Requirement: clinical data & isolate (isolate not req for C.auris cases)

Reward: Reimbursement & Authorship

Observation period: 04/2024 - 09/2025

Interested? 📧 [email protected] or DM
Antifungal resistance is growing – will new treatments turn the tables. Very happy to be featured in this important Nature outlook alongside many icons of the Mycology field.

www.nature.com/articles/d41...
Antifungal resistance is growing – will new treatments turn the tables?
Trials of drugs to fight deadly resistant infections are advancing, but they might fall victim to overuse of agricultural fungicides just like their predecessors.
www.nature.com
May 14, 2026 at 4:42 PM
Reposted by Martin Hoenigl
Excited to share our new publication: Clinical Characteristics, Management and Outcomes of Non-ICU Candidemia – a subanalysis of the ECMM Candida III multinational European cohort study. 😊

academic.oup.com/ofid/article...

@martinhoenigl.bsky.social @olivercornely.bsky.social
Clinical Characteristics, Management and Outcomes of Nonintensive Care Unit Candidemia: Subanalysis of the ECMM Candida III Multinational European Observational Cohort Study
A subanalysis of 396 candidemia cases diagnosed outside the intensive care unit from the pan-European multicenter ECMM Candida III study showed higher surv
academic.oup.com
April 13, 2026 at 7:23 AM
Reposted by Martin Hoenigl
Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature review

Work informing aims of @galactic-europe.bsky.social

Comgrats to all involved.

rdcu.be/fazXN
Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature review
rdcu.be
March 28, 2026 at 11:38 PM
Clinical characteristics, management and outcomes of non-ICU candidemia: Sub-analysis of the ECMM Candida III multinational European observational cohort study url: academic.oup.com/ofid/article...
Clinical characteristics, management and outcomes of non-ICU candidemia: Sub-analysis of the ECMM Candida III multinational European observational cohort study
Abstract. ECMM-Candida III was a pan-European, multicentre observational study of adult patients with blood culture-proven candidemia. Among a total of 632
academic.oup.com
March 28, 2026 at 11:29 PM
Mapping the landscape of endemic mycoses in India: Insights from a systematic review of reported cases spanning six decades (1960-2025)
@ofidjournal.bsky.social @drarghadip.bsky.social @grthompsonmd.bsky.social url: academic.oup.com/ofid/article...
Mapping the landscape of endemic mycoses in India: Insights from a systematic review of reported cases spanning six decades (1960-2025)
AbstractBackground. Endemic mycoses are caused by fungi inhabiting specific ecological niches. These infections remain underdiagnosed and underreported due
academic.oup.com
March 22, 2026 at 7:38 PM
Reposted by Martin Hoenigl
Mucorales PCR testing in Respiratory and Biopsy Samples from Immunocompromised Patients with Invasive Pulmonary Aspergillosis and other Mold Infections: Results from a Multicenter ECMM Study

✅ Just Accepted
https://bit.ly/3NxZoD2
Mucorales PCR testing in Respiratory and Biopsy Samples from Immunocompromised Patients with Invasive Pulmonary Aspergillosis and other Mold Infections: Results from a Multicenter ECMM Study
Mucormycosis is a severe fungal infection that is challenging to diagnose as traditional methods lack sensitivity and serological testi
bit.ly
January 8, 2026 at 8:51 PM
Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus | Microbiology Spectrum journals.asm.org/doi/10.1128/...
journals.asm.org
March 17, 2026 at 11:39 PM
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic.

Results of an ECMM multicenter study.

Big 🙏 to all involved and driving this project @agocarvalho.bsky.social and many more
Markers url: academic.oup.com/jid/article/...
Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic Markers
This multicenter study evaluated circulating immune biomarkers in patients with invasive aspergillosis to monitor treatment and predict outcome. Several pr
academic.oup.com
March 4, 2026 at 5:42 PM
Diagnostic accuracy of Mucorales PCR testing in bronchoalveolar lavage fluid samples: a retrospective analysis of a prospectively collected cohort - Clinical Microbiology and Infection www.clinicalmicrobiologyandinfection.org/article/S119...
Diagnostic accuracy of Mucorales PCR testing in bronchoalveolar lavage fluid samples: a retrospective analysis of a prospectively collected cohort
To evaluate the diagnostic performance, particularly specificity, of the MucorGenius® PCR assay for detecting pulmonary mucormycosis in bronchoalveolar lavage fluid (BALF) samples from at-risk patient...
www.clinicalmicrobiologyandinfection.org
March 1, 2026 at 12:04 PM
Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification | Journal of Clinical Microbiology
@ecmmcandidaiv.bsky.social @galactic-europe.bsky.social
journals.asm.org/doi/10.1128/...
Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification | Journal of Clinical Microbiology
Mucormycosis is a rapidly progressive and fatal fungal infection. Timely diagnosis is critical for effective treatment, yet current diagnostic tools are slow, insensitive, or require complex laborator...
journals.asm.org
March 1, 2026 at 11:55 AM
Reposted by Martin Hoenigl
Upcoming @idsainfo.bsky.social Immunocompromised Host COP and @msgerc.bsky.social webinar:

Feb 10, 2026 10:00 AM Central

"Testing Rationally in Mycology: Using Fungal Diagnostics to Drive Better Antifungal Decisions"

Sign up here:
societycentral.zoom.us/webinar/regi...
January 30, 2026 at 6:34 PM
Reposted by Martin Hoenigl
New webinar on fungal diagnostics!

Link in next post
January 19, 2026 at 1:10 PM
Reposted by Martin Hoenigl
Update on Candida IV study at #TIMM2025

Still open for registration 🔬🧫🧪
Join now!
January 13, 2026 at 8:11 AM
Reposted by Martin Hoenigl
Early mycological clearance in uncomplicated candidaemia can improve outcomes, reduce ICU stay, and lower healthcare costs. Timely antifungal therapy is key. Read more: doi.org/10.1111/myc.... @martinhoenigl.bsky.social

#Candidaemia #AntifungalTherapy #InfectiousDiseases #ICU #Healthcare
The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice
Invasive candidiasis is a life-threatening infection associated with high morbidity, mortality and healthcare costs in both general and critical care settings. Timely diagnosis and adequate antifunga....
doi.org
December 5, 2025 at 12:13 PM
Reposted by Martin Hoenigl
October 3, 2025 at 8:38 AM
Reposted by Martin Hoenigl
GALActIC Project – EU Collaboration Against IAPA | Consortium Meeting on Future Planning in Bilbao 🇪🇸

Galactic Europe: lnkd.in/d77xessA

@martinhoenigl.bsky.social
@simonfeys.bsky.social
@agocarvalho.bsky.social
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
October 3, 2025 at 10:52 AM
Reposted by Martin Hoenigl
✨📄 What about the untapped therapeutic potential of the immune response in invasive aspergillosis ? Here’s some rational, pre-clinical and clinical evidence. Huge thanks to our amazing 🌍 team!
🔗 bit.ly/46kajHr
@simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social
September 4, 2025 at 7:57 AM
🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

Groundbreaking work on a very promising new antifungal. Free access here:

authors.elsevier.com/c/1lHca5E-Uo...
authors.elsevier.com
June 18, 2025 at 7:59 AM
Reposted by Martin Hoenigl
🚨Our latest review in Thorax about the impact of climate change focusing on fungal pathogens in Europe 🌍

A truly enjoyable collaboration with Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social and @mbottery.bsky.social

thorax.bmj.com/content/earl...
June 12, 2025 at 6:08 AM
Reposted by Martin Hoenigl
Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge

@grthompsonmd.bsky.social and Angel Desai

www.nejm.org/doi/full/10....
Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge | NEJM
Use of some antifungal pesticides may select for resistant fungi in the environment, which can then endanger human health. Coordinated regulatory processes in this area are important.
www.nejm.org
June 8, 2025 at 5:39 PM
Reposted by Martin Hoenigl
Climate change: shifting boundaries of fungal disease in Europe and beyond

New review in Thorax

by @mbottery.bsky.social Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social @normanvanrhijn.bsky.social

thorax.bmj.com/content/thor... #MedSky #IDSky #PulmSky #ClimateSky #MedMycoSky
June 9, 2025 at 1:40 PM